Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ELRIAH Score: A Simple Score for HCC Risk Stratification in CHC Patients With Cirrhosis or Advanced Liver Fibrosis Who Achieved SVR Following DAA Therapy

NCT04173520 is registered in ClinicalTrials.gov with Egyptian Liver Hospital as lead sponsor.

NCT NCT04173520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04173520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ELRIAH Score: A Simple Score for HCC Risk Stratification in CHC Patients With Cirrhosis or Advanced Liver Fibrosis Who Achieved SVR Following DAA Therapy
Lead sponsor
Egyptian Liver Hospital
Phase
Observational
Overall status
Completed
Start date
January 31, 2015
Completion date
October 30, 2019
Enrollment
2,326 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hcc